IMZYLGO — 2506760
Application number
2506760
Type(s)
Standard Characters
Category
Trademark
CIPO Status
FORMALIZED
TM5 status
LIVE/APPLICATION/
Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
Filed
2026-10-09
Applicant
ABIVAX
7-11 Blvd. Haussmann
75009 PARIS,
FRANCE
Agent
ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP
630, boul. René-Lévesque Ouest
20e étage
Montréal
QUÉBEC H3B1S6
Documents
Index headings
- IMZYLGO
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract, namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis; Chemical preparations for medical purposes for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract, namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis; Chemical preparations for pharmaceutical purposes for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract,namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis
Claims
- Priority Filing Date: October 08, 2026, Country or Office: FRANCE, Application No. 5306665 in association with the same kind of goods
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2026-10-09 | ||
| Created | 2026-10-09 | ||
| Formalized | 2026-10-09 |